Application 022267
- Type
- NDA
- Sponsor
- ABBVIE INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DEPAKOTE ER | DIVALPROEX SODIUM | TABLET, EXTENDED RELEASE; ORAL | 250MG | No | No |
| 002 | DEPAKOTE ER | DIVALPROEX SODIUM | TABLET, EXTENDED RELEASE; ORAL | 500MG | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| divalproex sodium | DIVALPROEX SODIUM | Dr.Reddy's Laboratories Limited | 15f8a5be-e269-2e07-60d9-1dd7bf5f5281 | 2018-12-06 | Boxed warning, Warnings, Adverse reactions | DIVALPROEX SODIUM |
| Divalproex sodium | DIVALPROEX SODIUM | Aphena Pharma Solutions - Tennessee, LLC | ad5e8bd8-c923-40f0-a106-55620c4247d7 | 2018-10-16 | Boxed warning, Warnings, Adverse reactions | DIVALPROEX SODIUM |
| Divalproex Sodium | DIVALPROEX SODIUM | Aphena Pharma Solutions - Tennessee, LLC | b74adc5e-e92d-46a7-afdc-a6464a440bde | 2018-02-16 | Boxed warning, Warnings, Adverse reactions | DIVALPROEX SODIUM |
| Divalproex Sodium | DIVALPROEX SODIUM | Aphena Pharma Solutions - Tennessee, LLC | 9cfdcb58-d6d7-43bb-b6e1-17172b143296 | 2018-02-16 | Boxed warning, Warnings, Adverse reactions | DIVALPROEX SODIUM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.